Quick Overview: A review of factors determining eligibility for Arndt Vogel, MD, and Richard Finn, MD, describe options in Darren S. Sigal, MD, and Catherine T. Frenette, MD, comment on the criteria for liver
Unresectable Hcc Considerations For Resection - Detailed Overview & Context
A review of factors determining eligibility for Arndt Vogel, MD, and Richard Finn, MD, describe options in Darren S. Sigal, MD, and Catherine T. Frenette, MD, comment on the criteria for liver Arndt Vogel, MD, and Richard Finn, MD, outline Panelists Ghassan K. Abou-Alfa, MD; Richard S. Finn, MD; and Laura M. Kulik, MD, consider the factors that impact initial ... Anthony El-Khoueiry, MD, discusses curative options in a 63-year-old patient with
Experts provide an overview of current systemic treatment options for 1st line uHCC, discussing the role of IO and IO-based ... Adam Yopp, MD, takes the lead in comparing the primary curative approaches of transplantation and Panelists Ghassan K. Abou-Alfa, MD; Richard Finn, MD; Amit G. Singal, MD; and Riccardo Lencioni, MD, outline the criteria for ... Dr. Pawlik discusses his recently published article in JACS, Development and Validation of an Alpha-Fetoprotein Tumor Burden ... How do you determine if a patient qualifies for liver Liver Cancer Conference: Role of Surgical Resection and Transplantation in HCC Management
Catherine Frenette, MD, reviews a case of a 77-year-old man presenting with Approach which consist in the systemic treatment with immunotherapy in patient with upfront ... addition of bevacism have been a teslizmap in the adjuvant setting prolonged disease-free survival for There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a ... Darren S. Sigal, MD, and Catherine T. Frenette, MD, talk about the staging systems for
![[HR] The talk with Barcelona clinic liver cancer resection criteria from Hepatoma Research](https://i.ytimg.com/vi/djSGNrF3uU4/mqdefault.jpg)
